About: Degradation of Lung Protective Angiotensin Converting Enzyme-2 by Meconium in Human Alveolar Epithelial Cells: A Potential Pathogenic Mechanism in Meconium Aspiration Syndrome

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Degradation of Lung Protective Angiotensin Converting Enzyme-2 by Meconium in Human Alveolar Epithelial Cells: A Potential Pathogenic Mechanism in Meconium Aspiration Syndrome Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Degradation of Lung Protective Angiotensin Converting Enzyme-2 by Meconium in Human Alveolar Epithelial Cells: A Potential Pathogenic Mechanism in Meconium Aspiration Syndrome
Creator	Gandhi, Chintan Gewolb, Ira Holmes, Romel Uhal, Bruce
Source	Medline; PMC
abstract	BACKGROUND: Pancreatic digestive enzymes present in meconium might be responsible for meconium-induced lung injury. The local Renin Angiotensin System plays an important role in lung injury and inflammation. Particularly, angiotensin converting enzyme-2 (ACE-2) has been identified as a protective lung enzyme against the insult. ACE-2 converts pro-apoptotic Angiotensin II to anti-apoptotic Angiotensin 1–7. However, the effect of meconium on ACE-2 has never been studied before. OBJECTIVE: To study the effect of meconium on ACE-2, and whether inhibition of proteolytic enzymes present in the meconium reverses its effects on ACE-2. METHODS: Alveolar epithelial A549 cells were exposed to F-12 medium, 2.5% meconium, meconium + a protease inhibitor cocktail (PIc) and PIc alone for 16 h. At the end of incubation, apoptosis was measured with a nuclear fragmentation assay and cell lysates were collected for ACE-2 immunoblotting and enzyme activity. RESULTS: Meconium caused a fourfold increase in apoptotic nuclei (p < 0.001). The pro-apoptotic effect of meconium can be reversed by PIc. Meconium reduced ACE-2 enzyme activity by cleaving ACE-2 into a fragment detected at ~ 37 kDa by immunoblot. PIc prevented the degradation of ACE-2 and restored 50% of ACE-2 activity (p < 0.05). CONCLUSION: These data suggest that meconium causes degradation of lung protective ACE-2 by proteolytic enzymes present in meconium, since the effects of meconium can be reversed by PIc.
has issue date	2019-02-13(xsd:dateTime)
bibo:doi	10.1007/s00408-019-00201-y
bibo:pmid	30759273
has license	no-cc
sha1sum (hex)	6ec6ea6d41e9c00b249f42c79fd1b45a300254c6
schema:url	https://doi.org/10.1007/s00408-019-00201-y
resource representing a document's title	Degradation of Lung Protective Angiotensin Converting Enzyme-2 by Meconium in Human Alveolar Epithelial Cells: A Potential Pathogenic Mechanism in Meconium Aspiration Syndrome
has PubMed Central identifier	PMC7088148
has PubMed identifier	30759273
schema:publication	Lung
resource representing a document's body	covid:6ec6ea6d41e9c00b249f42c79fd1b45a300254c6#body_text
is schema:about of	named entity 'data' named entity 'lung' named entity 'digestive enzymes' named entity 'effects' named entity 'apoptotic' named entity 'ACE' named entity 'cleaving' named entity 'enzyme' named entity 'measured' named entity 'local' named entity 'meconium' named entity 'Renin' named entity 'Human' named entity 'Lung' named entity 'LOCAL' named entity 'STUDY' named entity 'LUNG' named entity 'ASSAY' named entity 'LUNG INJURY' named entity 'SUGGEST' named entity 'BACKGROUND' named entity 'ANGIOTENSIN CONVERTING ENZYME' named entity 'NEVER' named entity 'ACE' named entity 'CAUSES' named entity 'EPITHELIAL' named entity 'REDUCED' named entity 'PROTEASE INHIBITOR' named entity 'PRESENT' named entity 'RESPONSIBLE' named entity 'ANGIOTENSIN II' named entity 'INHIBITION' named entity 'IMMUNOBLOTTING' named entity '28P' named entity 'COLLECTED' named entity 'ANGIOTENSIN 1-7' named entity 'APOPTOSIS' named entity 'DIGESTIVE ENZYMES' named entity '0.001' named entity 'REVERSED' named entity 'INDUCED' named entity 'NUCLEAR FRAGMENTATION' named entity 'CONCLUSION' named entity '2.5' named entity 'IMMUNOBLOT' named entity 'COCKTAIL' named entity 'PANCREATIC' named entity 'EXPOSED TO' named entity '50%' named entity 'RESULTS' named entity 'ENZYME' named entity 'INCREASE' named entity 'OBJECTIVE' named entity '0.05' named entity 'CAUSED' named entity 'MEASURED' named entity 'LUNG' named entity 'PATHOGENIC' named entity 'ITS' named entity 'CELL' named entity 'DETECTED' named entity 'RENIN ANGIOTENSIN SYSTEM' named entity 'INSULT' named entity 'MEDIUM' named entity 'DEGRADATION' named entity 'PLAYS' named entity 'THESE' named entity 'EFFECT' named entity 'PROTEOLYTIC ENZYMES' named entity 'REVERSES' named entity 'MECONIUM' named entity 'ALVEOLAR EPITHELIAL CELLS' named entity 'DEGRADATION' named entity 'MECHANISM' named entity 'ANGIOTENSIN CONVERTING ENZYME' named entity 'ALVEOLAR' named entity 'A549 CELLS' named entity 'APOPTOTIC'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software